I'm skeptical of the complex capital raising structure, and the purchase price being nearly 6x current annual revenue, combined with no mention on profitability of operating cash flows or guidance of growth (other than warm fuzzy buzzy words), and the CAGR's mentioned weren't even that great in the first place (given the extreme price to revenue paid) and, perhaps more worryingly, seem to indicate growth has stalled, but hey, the hype is there and market loves it so congrats to holders. (Hopefully it lives up to the hype, as Z1P has a patchy record around acquisitions).
The only thing this really confirms is that FXL, with nearly 1.9m customers and 60k merchants is dirt cheap.
- Forums
- ASX - By Stock
- ZIP
- Ann: Acquisition of QuadPay and Capital Raise
Ann: Acquisition of QuadPay and Capital Raise, page-71
-
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZIP (ASX) to my watchlist
|
|||||
Last
$1.58 |
Change
-0.120(7.08%) |
Mkt cap ! $1.774B |
Open | High | Low | Value | Volume |
$1.72 | $1.72 | $1.57 | $42.26M | 26.16M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 19469 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 33400 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 19469 | 1.575 |
24 | 201490 | 1.570 |
8 | 332978 | 1.565 |
14 | 423682 | 1.560 |
5 | 110775 | 1.555 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 33400 | 3 |
1.585 | 243831 | 7 |
1.590 | 129069 | 8 |
1.595 | 30000 | 2 |
1.600 | 175967 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ZIP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online